Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Rongtai Health Technology FCF Margin % Chart
SHSE:603579 vs AS, HAS, LTH: FCF Margin % Comparison
For the Leisure subindustry, Shanghai Rongtai Health Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Rongtai Health Technology FCF Margin % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Rongtai Health Technology's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Rongtai Health Technology (SHSE:603579) has a FCF Margin % of 10.20% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 55% above median its historical median of 6.60. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #570 out of 839 companies in the Travel & Leisure industry, placing it in the top 67.9%.
Is Shanghai Rongtai Health Technology's FCF Margin % too high?
Shanghai Rongtai Health Technology's current FCF Margin % of 10.20% is 55% above median its 10-year median of 6.60. The Travel & Leisure industry median FCF Margin % is 5.57. Shanghai Rongtai Health Technology's value of 10.20% is 83.1% above this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #570 out of 839 companies in the Travel & Leisure industry, which is below the industry midpoint. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's FCF Margin % compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #570 out of 839 companies for FCF Margin %. This places Shanghai Rongtai Health Technology in the lower half of its industry. The industry median FCF Margin % is 5.57. Shanghai Rongtai Health Technology's value of 10.20% is 83.1% above this benchmark. While the company's 10-year median is 6.60 vs. the industry median of 5.57, Shanghai Rongtai Health Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Travel & Leisure company?
The median FCF Margin % among Travel & Leisure companies is 5.57, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current FCF Margin % of 10.20% is 83.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median FCF Margin % is 5.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current FCF Margin % is 10.20%, which is 55% above median its own 10-year median of 6.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.55, compared to a current price of ¥18.58 — trading 5.9% above its estimated fair value. The current FCF Margin % is 10.20%, which is 55% above median its 10-year median of 6.60 and 83.1% above the Travel & Leisure industry median of 5.57. Shanghai Rongtai Health Technology's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current FCF Margin % is 10.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥18.58 is trading 5.9% above its estimated GF Value™ of ¥17.55.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
FCF Margin %: 10.20% (55% above median its 10-year median of 6.60)
GF Value™: ¥17.55 vs. price of ¥18.58 (5.9% above fair value)
Industry Position: 83.1% above the Travel & Leisure median (#570 of 839)
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
69GF Score
Get the complete analysis for SHSE:603579
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
